Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
Clinical trial NCT00883896 · COMPLETED
Trial details
- NCT number
- NCT00883896
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-18
- Primary completion
- 2011-02-18
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.